NeuroOne Medical Technologies (NASDAQ:NMTC) Issues Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) issued its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative net margin of 308.51% and a negative return on equity of 276.12%.

NeuroOne Medical Technologies Stock Up 13.7 %

NeuroOne Medical Technologies stock opened at $0.86 on Tuesday. NeuroOne Medical Technologies has a 52-week low of $0.55 and a 52-week high of $1.72. The firm has a market capitalization of $26.50 million, a price-to-earnings ratio of -1.58 and a beta of 0.54. The company has a fifty day simple moving average of $0.82 and a 200-day simple moving average of $0.84.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.